David A. Siegel China Pharma Holdings, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.09 - $7.63 $9 - $763	-100 Reduced 0.43%	22,900 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $7.5 $84 - $4,500	-600 Reduced 2.54%	23,000 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.39 $924 - $1,716	-4,400 Reduced 15.71%	23,600 $5,000
Q1 2022 May 16, 2022	SELL	$0.34 - $0.5 $1,224 - $1,800	-3,600 Reduced 11.39%	28,000 $11,000
Q4 2021 Feb 14, 2022	BUY	$0.41 - $0.68 $7,134 - $11,832	17,400 Added 122.54%	31,600 $15,000
Q3 2021 Nov 15, 2021	BUY	$0.53 - $0.91 $7,526 - $12,922	14,200 New	14,200 $8,000

Ticker CPHI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 50,449,700
Market Cap $10.1M
Description
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. It...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.